Previous close | 82.44 |
Open | 83.20 |
Bid | 82.06 x 100 |
Ask | 82.27 x 100 |
Day's range | 81.99 - 83.58 |
52-week range | 76.02 - 99.56 |
Volume | |
Avg. volume | 1,578,145 |
Market cap | 15.596B |
Beta (5Y monthly) | 0.32 |
PE ratio (TTM) | 77.49 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
New drug approvals and pipeline progress are likely to help maintain the momentum for the Zacks Biomedical and Genetics industry. A strong portfolio and solid pipeline progress position BMRN, BPMC, IMVT, KYMR and LGND well amid volatility.
Last week, you might have seen that BioMarin Pharmaceutical Inc. ( NASDAQ:BMRN ) released its first-quarter result to...
Insightful Analysis of Biomarin Pharmaceutical Inc's Strengths, Weaknesses, Opportunities, and Threats